Feb 2, 2025 | False Claims Act, federal investigations, Fraud Investigations, Government Investigations
On February 1, 2025, President Trump announced the imposition of substantial tariffs on goods imported from Canada, Mexico, and China. These tariffs are likely to come with an increase in customs enforcement, with customs officials ensuring that incoming goods are...
Jan 16, 2025 | False Claims Act
On January 15, 2025, the DOJ announced that its False Claims Act (FCA) recovery for fiscal year 2024 (which ended on September 30, 2024) exceeded $2.9 billion. This figure is slightly higher than the total recovery from the prior fiscal year ($2.7B) and the year...
Jan 14, 2025 | Administrative Law, False Claims Act, Fraud Investigations, Health Care, Health Care Fraud
Late last year, President Biden signed the annual National Defense Authorization Act (NDAA) for fiscal year 2025. This alone is not newsworthy, as this has happened every year since the NDAA was introduced in 1961. Generally speaking, the NDAA governs Department of...
Jan 8, 2025 | False Claims Act, Fraud Investigations
Although False Claims Act cases involving federal grant fraud may not be as common as those involving healthcare fraud, the consequences of such cases can be just as significant. Recently, Athira Pharma, a Washington state-based biopharmaceutical company, agreed to...
Oct 14, 2024 | False Claims Act, Health Care, Health Care Fraud, White Collar Crime
On October 10, 2024, the DOJ announced that Teva Pharmaceuticals had agreed to pay $450 million to resolve two matters, one of which was the result of an investigation conducted pursuant to the False Claims Act (FCA). According to the DOJ, the settlement encompasses...
